Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Lupus pneumonitis can mimic tuberculosis and should be considered in diagnoses.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Low-intensity ultrasound may help protect hair follicles from chemotherapy-induced hair loss.

The method could improve vitiligo treatment by effectively delivering therapy to hair follicles.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Clofazimine may be effective for treating ashy dermatosis.

The scaffold helps wounds heal without scars and promotes hair growth.

New treatments for lupus show promise, but more research is needed, especially for children.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

A patient with lupus experienced a condition where their immune cells became overactive.

Using cidofovir cream for a rare skin disease can cause skin darkening.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

A new method improves betulin delivery and shows promise in cancer treatment.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

Betulinic acid can help treat hepatitis C by stopping virus replication.